184
Views
6
CrossRef citations to date
0
Altmetric
Original Research

LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment

, , , , , , , , , & show all
Pages 203-220 | Published online: 22 Mar 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (6)